Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
10
×
life sciences
national blog main
national top stories
10
×
biotech
boston blog main
boston top stories
clinical trials
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boston
deals
national
novartis
alnylam pharmaceuticals
amgen
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
europe blog main
gilead sciences
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
sanofi
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
What
medicines
10
×
drug
fda
new
announced
approval
bio
class
covid
deal
ipo
migraine
monday
nod
pharmaceuticals
research
roche
roundup
team
wins
acquire
acquisitions
activity
adults
agreed
allergan
amgen
approvals
approved
backs
bets
billion
biogen
biotechs
blueprint
brings
cancer
candidate
candidates
cash
Language
unset
unknown
Current search:
medicines
×
" national top stories "
×
fda
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines